Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Sofosbuvir Polymorphic Form 6

Polymorphs
CAT No.
:
CS-O-11237

CAS No.

:

NA

Molecular Weight

:

529.45

Molecular Formula

:

C22H29FN3O9P

Purity

:

>98%

 


Useful information

"Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir, or daclatasvir. Cure rates are 30 to 97% depending on the type of hepatitis C virus involved. Safety during pregnancy is unclear; while, some of the medications used in combination may result in harm to the baby. It is taken by mouth.

Common side effects include feeling tired, headache, nausea, and trouble sleeping. Side effects are generally more common in interferon-containing regimens. Sofosbuvir may reactivate hepatitis B in those who have been previously infected. In combination with ledipasvir, daclatasvir or simeprevir it is not recommended with amiodarone due to the risk of an abnormally slow heartbeat. Sofosbuvir is in the nucleotide analog family of medication and works by blocking the hepatitis C NS5B protein.

Sofosbuvir was discovered in 2007 and approved for medical use in the United States in 2013. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. As of 2016 a 12-week course of treatment costs about $84,000 in the United States, $53,000 in the United Kingdom, $45,000 in Canada, and $483 in India. Over 60,000 people were treated with sofosbuvir in its first 30 weeks being sold in the United States.",""



Product Application Notes

Sofosbuvir Polymorph



References

Divya Rajagopal for the Economic Times. Sept 12, 2015;Tran TT (December 2012).



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Sofosbuvir Polymorphic Form 6 Cas # NA and its Polymorphs.

Sofosbuvir Polymorphic Form 6 Sofosbuvir Polymorphic Form 6 Worldwide Suppliers of Sofosbuvir Polymorphic Form 6 Polymorphs Clearsynth NA

Product rating: 9 Sofosbuvir Polymorphic Form 6 based on 20 ratings

  1. Polymorphs

  2. Sofosbuvir Polymorphic Form 6



Keywords

Keywords: Polymorphs CS-O-11237 Sofosbuvir Polymorphic Form 6 Sofosbuvir NA 529.45 C22H29FN3O9P



Related result for 'Sofosbuvir Polymorphic Form 6'

- Sofosbuvir : API Standards

- Sofosbuvir : Stable Isotopes

- Sofosbuvir : Metabolites

- Sofosbuvir : Impurities

- Sofosbuvir : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945